Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

newsfilter.ioAug 30 08:00 ET

Vaxart's Pre-clinical Data Reveals Potential Of Mucosal Vaccine Platform For HPV- Cervical Dysplasia

RTTNewsAug 28 10:09 ET

Vaxart Dips on Test Results

Baystreet.caAug 28 09:52 ET

Express News | Vaxart- Co's Hpv Vaccine Constructs Can Stimulate Potent Immune Response Against Hpv16 Proteins E6 & E7

ReutersAug 28 08:04 ET

Express News | Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of Its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for Hpv-Related Cervical Dysplasia

ReutersAug 28 08:00 ET

Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of Its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV-Related Cervical Dysplasia

VaxartAug 28 00:00 ET